Exploring Tau Biology Through Blood-Based Biomarkers

SPEAR BIO LUNCH & LEARN

Exploring Tau Biology Through Blood-Based Biomarkers

Banner Health | Lunch & Learn

Date: Wednesday, September 30, 2026
Time: 12:00 p.m.
Location: Fluid Biomarker Conference Room, 3rd Floor 
Lunch: Complimentary lunch will be provided

Explore Emerging Approaches to Alzheimer’s Biomarker Research

Blood-based biomarkers are creating new opportunities to investigate Alzheimer’s disease biology across distinct aspects of pathology—from amyloid-associated tau phosphorylation to tau tangle formation.

Join us for an interactive Lunch & Learn exploring how emerging tau biomarkers, including epTau 217 and eMTBR-Tau, can provide complementary biological information for Alzheimer’s disease research. We’ll also introduce the science behind SPEAR’s homogeneous, wash-free immunoassay technology and discuss how automated, low-volume workflows can support biomarker studies.

Bring your questions and research challenges and join Spear Bio and fellow Banner Health researchers for lunch, scientific discussion, and Q&A.

What You’ll Learn

• Explore how different blood-based tau biomarkers can provide complementary views of Alzheimer’s disease biology.
• Understand the biological distinction between epTau 217 and eMTBR-Tau and where each may contribute to biomarker research.
• Learn how homogeneous, wash-free SPEAR technology enables sensitive protein biomarker measurement from very low sample volumes.
• See how SPEAR S.W.I.F.T.™ automates the SPEAR workflow from sample preparation through a qPCR-ready plate.
• Discuss opportunities and considerations for incorporating emerging biomarkers into translational and clinical research studies.

Presented By:

Tufan Aydogdu
Sr Business Development Manager, West Coast, Spear Bio